UNSPSC 51311610: Nedocromil sodium

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H15NO7.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ET8IF4KS1T, chemically known as 4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt but more generally known as nedocromil sodium, which bears US NIH Compound Identifier 50295. European Medicines Agency schedules Nedocromil sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14634MIG.

UNSPSC 51311610 Nedocromil sodium is a Commodity code that designates pharmaceutical active ingredients for respiratory and anti-inflammatory applications. Recent state and local procurement activity under this code shows minimal alignment with the code's nominal scope; the single identified opportunity involves naloxone and drug deactivation systems rather than nedocromil sodium formulations. County health departments and emergency-services agencies appear to be the primary issuing bodies, though the activity recorded is sparse and does not reflect sustained procurement demand for the nedocromil sodium ingredient itself.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 at 2:00 pm. The contract carries a two-year initial term with an optional one-year renewal, fixed-fee pricing, and potential FEMA funding with associated federal compliance requirements. This opportunity represents a material mismatch with the code's pharmaceutical-ingredient designation and suggests that the code shows little relevant recent activity for nedocromil sodium procurement at the state and local level.